Epigenetics in cancer


Epigenetic mechanisms are especially for normal development and maintenance of tissue-specific gene expression patterns in humans. Disordering of epigenetic processes can guide to altered gene function and malignant cellular transformation. Global changes in the epigenetic are a sign of cancer. The starting level of cancer, commonly seen as a genetic disease, but now known to involve epigenetic abnormalities along with genetic alterations. Advancements in the fast evolving area of cancer epigenetics have shown extensive reprogramming of every component of the epigenetic machinery in cancer including DNA methylation, histone modifications, nucleosome positioning and non-coding RNAs, specifically microRNA expression.



 


  • Adenocarcinoma
  • Squamous Cell Carcinoma
  • Large Cell Carcinoma
  • Adenosquamous Carcinoma
  • Carcomatoid Carcinoma

Related Conference of Epigenetics in cancer

November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
November 28-29, 2024

14th World Congress on Breast Cancer

Paris, France
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE
December 11-12, 2024

34th Experts Meet On Cancer Research & Therapy

Paris, France
December 12-13, 2024

44th Euro Congress on Cancer Science & Therapy

Rome, Italy
March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands

Epigenetics in cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in